People · Operator

Jian-min John Mao, Ph.D.

Named in public records as an officer, director or promoter · active 2009–2009 · Other Health Care

1
Companies
1
Filings
$8.2M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Vioptix IncOther Health CareSeed$8.2M$70.1M2009
Operator network

Jian-min John Mao, Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

W. Gregory Shearer · 2 companies · 1 sharedW. Gregory ShearerAlex A. Keller, M.D. · 1 companies · 1 sharedAlex A. Keller, M…Alex John Keller, M.D. · 1 companies · 1 sharedAlex John Keller,…Bob John Lash, M.D. · 1 companies · 1 sharedBob John Lash, M.…George A. Gardiner · 1 companies · 1 sharedGeorge A. GardinerJennifer John Hamilton · 1 companies · 1 sharedJennifer John Ham…Jian-min A. Mao, Ph.D. · 1 companies · 1 sharedJian-min A. Mao, …L. John Lloyd · 1 companies · 1 sharedL. John LloydMark A. Lonsinger · 1 companies · 1 sharedMark A. LonsingerMark John Lonsinger · 1 companies · 1 sharedMark John Lonsing…Michael A. Cross · 1 companies · 1 sharedMichael A. CrossScott E. Coleridge · 1 companies · 1 sharedScott E. ColeridgeVictor A. Colunga · 1 companies · 1 sharedVictor A. ColungaVioptix Inc · $8.2M raisedVioptix IncJian-min John Mao, Ph.D.JP
Jian-min John Mao, Ph.D. Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jian-min John Mao, Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
W. Gregory Shearer12
Jennifer John Hamilton11
Scott E. Coleridge11
Alex John Keller, M.D.11
Mark John Lonsinger11
Jian-min A. Mao, Ph.D.11
George A. Gardiner11
Bob John Lash, M.D.11
Alex A. Keller, M.D.11
Michael A. Cross11
Mark A. Lonsinger11
L. John Lloyd11
Victor A. Colunga11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.